cladribine has been researched along with Anemia, Hemolytic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohlius, J; Greil, R; Pall, G; Richards, S; Schwarzer, G; Steurer, M | 1 |
| Bauer, F; Beham-Schmid, C; Brezinschek, R; Jaeger, G; Mannhalter, C; Neumeister, P | 1 |
| Piatkowska-Jakubas, B; Skotnicki, AB | 1 |
| Delannoy, A; Devogelaer, JP; Houssiau, FA | 1 |
1 review(s) available for cladribine and Anemia, Hemolytic
| Article | Year |
|---|---|
Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.
Topics: Anemia, Hemolytic; Antineoplastic Agents; Cladribine; Disease-Free Survival; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Pentostatin; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vidarabine | 2006 |
3 other study(ies) available for cladribine and Anemia, Hemolytic
| Article | Year |
|---|---|
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
Topics: Adult; Alemtuzumab; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Transfusion; Cladribine; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Lymphoma, T-Cell; Neutropenia; Prednisolone; Receptors, Antigen, T-Cell, gamma-delta; Recurrence; Remission Induction; Rituximab; Splenic Neoplasms; Vincristine | 2008 |
[Hematologic remission and disappearance of hemolytic anemia in chronic lymphocytic leukemia after therapy with 2-chlorodeoxyadenosine (2-CDA)].
Topics: Anemia, Hemolytic; Autoimmune Diseases; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocyte Count; Male; Middle Aged; Remission Induction | 1993 |
Paradoxical immunologic effects of 2-CdA therapy: comment on the article by Davis et al.
Topics: Anemia, Hemolytic; Antibodies, Antinuclear; Arthritis, Rheumatoid; Cladribine; Female; Humans; Immune System Diseases; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Nephritis; Lymphopenia; Male; Middle Aged | 1998 |